Beneath the COVID-19 headlines, WCBS’ CEO Radio talks with Isoray CEO Lori Woods about Cesium-131 internal radiation therapy and making a difference in treating people with cancer.
American Brachytherapy Society LDR Prostate Brachytherapy Treatment Consensus Paper Recognizes Isoray’s Cesium-131
RICHLAND, WASHINGTON – September 28, 2021 – The American Brachytherapy Society (ABS) has recognized Isoray’s Cesium-131 in its recently released new consensus statement on the subject of low dose rate (LDR) prostate brachytherapy. This marks the first time Cesium-131...